Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Bone Marrow Transplantation|June 5, 1998
Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphomaE Aurlien, H Holte, A Pharo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 10, 2004
Use of complementary and alternative therapies: a national multicentre study of oncology health professionals in NorwayA Kolstad, T Risberg, Y Bremnes, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 10, 1996
[Treatment with growth factors and cytokines in hematologic diseases]A Waage, I M Dahl, S A Evensen, et al.
Acta Oncologica (Stockholm, Sweden)|July 27, 1999
Late medical sequelae after therapy for supradiaphragmatic Hodgkin's diseaseA F Abrahamsen, J H Loge, E Hannisdal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up timeA Foss Abrahamsen, A Andersen, O Nome, et al.
European Journal of Haematology|February 1, 1997
Systemic pneumococcal disease after staging splenectomy for Hodgkin's disease 1969-1980 without pneumococcal vaccine protection: a follow-up study 1994A Foss Abrahamsen, E A Høiby, E Hannisdal, et al.
Scandinavian Journal of Immunology|May 1, 1990
Inhibition of polyphosphoinositide breakdown and c-myc induction accompanying inhibition of human B-cell activation by two monoclonal antibodies against the leucocyte common antigen (CD45)E B Smeland, H Holte, H Kiil Blomhoff, et al.
Bone Marrow Transplantation|June 1, 2004
A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantationM J Hjermstad, H Knobel, L Brinch, et al.
British Journal of Cancer|December 19, 2001
Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphomaT Stokke, P DeAngelis, L Smedshammer, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Prognostic variables and results of salvage treatment in Hodgkin's diseaseA F Abrahamsen, E Hannisdal, O Nome, et al.
Pageof 10